Irinotecan Hydrochloride
Product Images NDC 72485-211

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Irinotecan Hydrochloride (NDC 72485-211). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Armas Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Fig3)

A survival curve chart comparing Second-Line Irinotecan versus Best Supportive Care (BSC) from Study 7. The y-axis represents survival probability from 0 to 1.0, and the x-axis shows months from 0 to 21. Two curves display the survival trends for Irinotecan (N=189) and BSC (N=90), with median follow-up of 13 months and median survival of 9.2 months for Irinotecan and 6.5 months for BSC. A p-value of 0.0001 from a log-rank test is noted, indicating statistical analysis of survival differences.*

FDA Label Image

Image Description (Fig4)

A survival curve chart comparing second-line treatment with Irinotecan versus infusion 5-FU in Study 8. The y-axis shows survival probability declining from 1.0 to 0.0, and the x-axis shows months from 0 to 21. The graph indicates higher survival probability over time for Irinotecan compared to 5-FU, with median follow-up of 10.8 months for Irinotecan and 8.5 months for 5-FU, and a significant p-value of 0.0035 from a log-rank test.*

FDA Label Image

Image Description (Label1.2)

Label for Irinotecan Hydrochloride Injection USP, 40 mg/2 mL (20 mg/mL) in a 2 mL single-dose vial. The sterile aqueous solution is labeled for intravenous use only and distributed by Armas Pharmaceuticals Inc. Storage instructions specify 20° to 25°C (68° to 77°F), protecting from light and freezing. The label includes a caution for cytotoxicity, manufacturing by Shilpa Medicare Limited, India, and a barcode with NDC 72485-211-02.*

FDA Label Image

Image Description (Structure)

Chemical structure of irinotecan hydrochloride trihydrate, the active ingredient in Irinotecan Hydrochloride 40 mg/2 mL by Armas Pharmaceuticals Inc. The diagram depicts the molecular composition including ring structures and functional groups characteristic of this compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.